Get alerts for new trials in your area by subscribing now
Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program
for
Tics, Tic Disorders, Tourette Syndrome
Location: Milwaukee WI, Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 7+
Code: NCT05547854
Recruiting
The Minimalist Trial-2
for
HPV-Related Oropharynx Squamous Cell Carcinoma
Location: St Louis MO, Fargo ND, Sioux Falls SD
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT06702033
Phase2, Recruiting
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: The Bronx NY, Newark NJ, New Brunswick NJ, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05172245
Phase1, Recruiting
Peanuts for Cardiometabolic, Brain, and Intestinal Health
for
Prediabetes,
Location: Atlanta GA
Sponsor: Georgia State University
Sex: All
Age: 20 - 59
Code: NCT06867198
Recruiting
PIB for Post-operative Analgesia After Laparotomy : Determining the Optimum Dose
for
Acute Post Operative Pain, Laparotomy, Epidural Analgesia
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal
Sex: All
Age: 18 - 70+
Code: NCT05534945
Recruiting
Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
Sponsor: Institut für Pharmakologie und Präventive Medizin
Sex: All
Age: 18+
Code: NCT05601453
Recruiting
A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
for
Hematopoietic Cell Transplantation
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Duke University
Sex: All
Age: 0 - 26
Code: NCT05090345
Recruiting
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
for
KRAS P.G12C
Location: Sarasota FL, Detroit MI, Nashville TN, Houston TX,
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT05410145
Phase1, Phase2, Recruiting
MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
for
Anal Squamous Cell Carcinoma
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT06050707
Phase2, Recruiting
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
for
Glioma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT01772771
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Halifax, Worcester MA, Montreal, Media PA, Newark DE,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT05920356
Phase3, Recruiting
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma